Diagnostics & Research Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4280 | STRR Star Equity Holdings, Inc. - Common Stock | 10.35 USD | +6.59% | +4.65% | +4.55% | -6.76% | 38.19 M USD | ||
| 4384 | MDXH MDxHealth SA - American Depositary Shares | 0.58 USD | -3.33% | 0.00% | -19.44% | -87.11% | 29.79 M USD | ||
| 4704 | NDRA ENDRA Life Sciences Inc. - Common Stock | 5.93 USD | -2.15% | +0.51% | +2.77% | +75.96% | 8.89 M USD | ||
| 4729 | ADVB Advanced Biomed Inc. - Common Stock | 6.30 USD | 0.00% | -8.96% | -28.65% | +2900.00% | 8.71 M USD | ||
| 4746 | XWEL XWELL, Inc. - Common Stock | 0.92 USD | +2.22% | +10.84% | -4.17% | -8.00% | 7.90 M USD | ||
| 4872 | BIAF bioAffinity Technologies, Inc. - Common Stock | 6.22 USD | +0.97% | -4.75% | -42.46% | +409.84% | 3.36 M USD | ||
| 4887 | TRIB Trinity Biotech plc - American Depositary Shares each represent | 6.12 USD | -9.73% | -3.16% | -35.37% | +456.36% | 3.82 M USD | ||
| 4912 | VNRX VolitionRX Limited Common Stock | 0.22 USD | 0.00% | -8.33% | -33.33% | 0.00% | 3.00 M USD | ||
| 4924 | ISPC iSpecimen Inc. - Common Stock | 1.07 USD | -2.73% | -6.96% | -32.70% | +256.67% | 2.69 M USD | ||
| 6278 | NOTV Inotiv, Inc. - Common Stock | 0.08 USD | 0.00% | -33.33% | -70.37% | -94.67% | 2.79 M USD | ||
| 6836 | PRENW Prenetics Global Limited - Warrant | 0.0082 USD | -24.77% | -3.53% | -41.43% | -76.70% | 371.06 M USD | ||
| 7166 | STRRP Star Equity Holdings, Inc. - 10% Series A Cumulative Perpetual Preferred Stock | 9.19 USD | 0.00% | -0.65% | -5.45% | -5.36% | 38.19 M USD | ||
| 7260 | BIAFW bioAffinity Technologies, Inc. - Warrant | 0.4080 USD | +14.90% | -23.74% | -35.65% | -38.67% | 3.36 M USD |
Nachrichten Diagnostics & Research Stocks
Myriad Genetics und SOPHiA GENETICS kooperieren mit AstraZeneca bei Prostatakrebs-Biomarker
SOPHiA GENETICS und Myriad Genetics arbeiten zusammen, um die neue technologie zur genomischen Instabilitätsbewertung speziell für Prostatakrebs voranzutreiben
Dieser Generac-Analyst nimmt die Beobachtung mit einer optimistischen Einschätzung auf; hier sind die 5 wichtigsten Erstbewertungen für Donnerstag
Jefferies nimmt die Bewertung von Twist Bioscience mit der Einstufung „Hold“ auf und gibt ein Kursziel von 150 US-Dollar bekannt
Argenx, Caribou Biosciences und andere große Aktien mit Kursverlusten im vorbörslichen Handel am Donnerstag
Twist Bioscience: Jefferies startet Coverage mit ’Hold’ – Aktie bereits über Kursziel
Charles River Labs: Top-Managerin verkauft Aktien im Wert von 302.579 $
Gainers Diagnostics & Research Stocks
BIAFW bioAffinity Technologies, Inc. - Warrant | 0.4080 | +14.90% |
ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.71 | +9.12% |
STRR Star Equity Holdings, Inc. - Common Stock | 10.35 | +6.59% |
NEOG Neogen Corporation - Common Stock | 12.04 | +3.08% |
XWEL XWELL, Inc. - Common Stock | 0.92 | +2.22% |
IDXX IDEXX Laboratories, Inc. - Common Stock | 511.85 | +1.02% |
DGX Quest Diagnostics Incorporated Common Stock | 229.21 | +0.99% |
BIAF bioAffinity Technologies, Inc. - Common Stock | 6.22 | +0.97% |
Losers Diagnostics & Research Stocks
PRENW Prenetics Global Limited - Warrant | 0.0082 | -24.77% |
TRIB Trinity Biotech plc - American Depositary Shares each represent | 6.12 | -9.73% |
DRIO DarioHealth Corp. - Common Stock | 5.55 | -8.72% |
IMDX Insight Molecular Diagnostics Inc. - Common Stock | 3.19 | -7.80% |
TWST Twist Bioscience Corporation - Common Stock | 149.78 | -3.77% |
BDSX Biodesix, Inc. - Common Stock | 25.46 | -3.63% |
MDXH MDxHealth SA - American Depositary Shares | 0.58 | -3.33% |
LAB Standard BioTools Inc. - Common Stock | 0.66 | -2.94% |